Live Breaking News & Updates on Corcept therapeutics

Stay informed with the latest breaking news from Corcept therapeutics on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Corcept therapeutics and stay connected to the pulse of your community

Corcept Therapeutics (CORT) Scheduled to Post Earnings on Wednesday

Corcept Therapeutics (NASDAQ:CORT – Get Free Report) is scheduled to announce its earnings results after the market closes on Wednesday, May 1st. Analysts expect the company to announce earnings of $0.18 per share for the quarter. Investors interested in participating in the company’s conference call can do so using this link. Corcept Therapeutics (NASDAQ:CORT – […]

United-states , Danieln-swisher-jr , Joseph-douglas-lyon , Corcept-therapeutics-incorporated , Corcept-therapeutics-company-profile , Corcept-therapeutics , Get-free-report , Director-daniel , Therapeutics-incorporated , Corcept-therapeutics-daily , Nasdaq-cort , Cort

Corcept Therapeutics (NASDAQ:CORT) Given "Buy" Rating at HC Wainwright

HC Wainwright reissued their buy rating on shares of Corcept Therapeutics (NASDAQ:CORT – Free Report) in a report issued on Tuesday morning, Benzinga reports. HC Wainwright currently has a $38.00 price target on the biotechnology company’s stock. Other equities research analysts also recently issued reports about the stock. Truist Financial lifted their price target on […]

Cambridge , Cambridgeshire , United-kingdom , United-states , Illinois , Joseph-douglas-lyon , Sean-maduck , Allspring-global-investments-holdings , Securities-exchange-commission , Corcept-therapeutics-incorporated , Cambridge-investment-research-advisors-inc , Hightower-advisors

Corcept Therapeutics' (CORT) "Buy" Rating Reaffirmed at HC Wainwright

Corcept Therapeutics' (CORT) "Buy" Rating Reaffirmed at HC Wainwright
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states , Illinois , Cambridge , Cambridgeshire , United-kingdom , Sean-maduck , Danieln-swisher-jr , Cambridge-investment-research-advisors-inc , Illinois-municipal-retirement-fund , Linden-thomas-advisory-services , Securities-exchange-commission , Corcept-therapeutics-incorporated

HC Wainwright Reaffirms "Buy" Rating for Corcept Therapeutics (NASDAQ:CORT)

HC Wainwright Reaffirms "Buy" Rating for Corcept Therapeutics (NASDAQ:CORT)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states , Cambridge , Cambridgeshire , United-kingdom , Danieln-swisher-jr , Joseph-douglas-lyon , Norden-group , Allspring-global-investments-holdings , Corcept-therapeutics-incorporated , Raymond-james-financial-services-advisors-inc , Securities-exchange-commission , Milestone-asset-management

Linden Thomas Advisory Services LLC Has $1.84 Million Stock Position in Corcept Therapeutics Incorporated (NASDAQ:CORT)

Linden Thomas Advisory Services LLC Has $1.84 Million Stock Position in Corcept Therapeutics Incorporated (NASDAQ:CORT)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states , Danieln-swisher-jr , Zurcher-kantonalbank-zurich-cantonalbank , Joseph-douglas-lyon , Corcept-therapeutics-company-profile , Corcept-therapeutics-incorporated , Securities-exchange-commission , Cornerstone-investment-partners , Cornercap-investment-counsel-inc , Mackenzie-financial-corp , Linden-thomas-advisory-services , Free-report

Corcept Therapeutics (NASDAQ:CORT) Stock Price Down 3.3%

Corcept Therapeutics (NASDAQ:CORT) Stock Price Down 3.3%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states , Joseph-douglas-lyon , Danieln-swisher-jr , Milestone-asset-management , Alphamark-advisors , Allspring-global-investments-holdings , Norden-group , Corcept-therapeutics-incorporated , Raymond-james-financial-services-advisors-inc , Get-free-report , Corcept-therapeutics , Truist-financial

Hussman Strategic Advisors Inc. Has $1.71 Million Stock Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT)

Hussman Strategic Advisors Inc. cut its stake in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) by 16.7% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 52,500 shares of the biotechnology company’s stock after selling 10,500 shares during the period. Hussman Strategic Advisors […]

United-states , Joseph-douglas-lyon , Sean-maduck , Hussman-strategic-advisors-inc , Morgan-stanley , Corcept-therapeutics-incorporated , Blackrock-inc , Nasdaq , Norges-bank , Securities-exchange-commission , Vanguard-group-inc , Hussman-strategic-advisors

Investigational Cushing's syndrome medication reduces BP, glucose in open-label trial

Investigational Cushing's syndrome medication reduces BP, glucose in open-label trial
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Richard-smith , Corcept-therapeutics ,

Mid-Cap Corcept Therapeutics Reveals Data From Hormonal Disorder Study, FDA Application Submission Expected This Quarter - Corcept Therapeutics (NASDAQ:CORT)

Insights from Corcept Therapeutics' Phase 3 GRACE trial results for endogenous Cushing's syndrome. Discover rapid improvements in hypertension and hyperglycemia without adverse effects. Join us for the upcoming medical conference in June.

Corcept-therapeutics , Price-action ,

Corcept Therapeutics (NASDAQ:CORT) Downgraded to "Buy" at StockNews.com

Corcept Therapeutics (NASDAQ:CORT) Downgraded to "Buy" at StockNews.com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states , Joseph-douglas-lyon , Sean-maduck , Nasdaq , Fintrust-capital-advisors , Investment-advisers , Corcept-therapeutics-incorporated , Lazard-asset-management , Corcept-therapeutics , Free-report , Get-free-report , Trust-capital-advisors